Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
EJNMMI Physics
|
October 27, 2015
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy
Wietske Woliner-van der Weg, Rafke Schoffelen, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome
Anne I J Arens, Esther G C Troost, Bianca A W Hoeben, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2014
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
Rafke Schoffelen, Wietske Woliner-van der Weg, Eric P Visser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2007
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
L F de Geus-Oei, H W M van Laarhoven, E P Visser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 21, 2013
Multicenter harmonization of 89Zr PET/CT performance
Nikolaos E Makris, Ronald Boellaard, Eric P Visser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer
Lioe-Fee de Geus-Oei, Henricus F M van der Heijden, Eric P Visser, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 30, 2014
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma
Olga C J Schuurbiers, Tineke W H Meijer, Johannes H A M Kaanders, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2011
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning
Marshall W Huston, Niek P van Til, Trudi P Visser, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2013
Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome
Niek P van Til, Roya Sarwari, Trudi P Visser, et al.
Journal of Internal Medicine
|
August 25, 2004
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
B Winblad, K Palmer, M Kivipelto, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
EJNMMI Physics
|
October 27, 2015
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy
Wietske Woliner-van der Weg, Rafke Schoffelen, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome
Anne I J Arens, Esther G C Troost, Bianca A W Hoeben, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2014
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
Rafke Schoffelen, Wietske Woliner-van der Weg, Eric P Visser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 27, 2007
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
L F de Geus-Oei, H W M van Laarhoven, E P Visser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 21, 2013
Multicenter harmonization of 89Zr PET/CT performance
Nikolaos E Makris, Ronald Boellaard, Eric P Visser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer
Lioe-Fee de Geus-Oei, Henricus F M van der Heijden, Eric P Visser, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 30, 2014
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma
Olga C J Schuurbiers, Tineke W H Meijer, Johannes H A M Kaanders, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2011
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning
Marshall W Huston, Niek P van Til, Trudi P Visser, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2013
Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome
Niek P van Til, Roya Sarwari, Trudi P Visser, et al.
Journal of Internal Medicine
|
August 25, 2004
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
B Winblad, K Palmer, M Kivipelto, et al.
Page
of 23